NCT07719517 Morning Activation to Improve Mood After Stroke
| NCT ID | NCT07719517 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-05-15 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-05-15 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot randomized controlled trial will evaluate the feasibility and preliminary effects of a six-week behavioral intervention designed to improve mood and daily functioning in adults who have experienced a stroke and report depressive symptoms and difficulty becoming engaged in activities after waking. Participants will be randomly assigned to either the behavioral intervention or a health education program. Assessments will be completed before and immediately after the six-week program and will include questionnaires and seven-day monitoring of sleep, activity, and mood. The study will also examine feasibility indices such as participant retention, intervention attendance, acceptability, and preliminary changes in mood.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older. * History of stroke at least 6 months before enrollment. * Patient Health Questionnaire-9 score of 10 or higher. * Difficulty getting started or engaging in activities in the morning. * Able to provide informed consent. Exclusion Criteria: * Conditions that would interfere with study participation. * Neurological condition other than stroke. * Currently receiving psychological therapy for depression. * Significant cognitive impairment or dementia. * Current or past diagnosis of psychosis, bipolar disorder, or mania. * Hospitalization that would interfere with study participation. * Acute or significant suicidal ideation * Alcohol or substance use problems within the past month. * Use of antidepressant or anti-anxiety medication unless the dosage has been stable for at least 4 weeks and no changes are planned during the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07719517 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07719517 currently recruiting?
Yes, NCT07719517 is actively recruiting participants. Contact the research team at chun-lun-stephen.lau@polyu.edu.hk for enrollment information.
Where is the NCT07719517 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07719517 clinical trial?
NCT07719517 is sponsored by The Hong Kong Polytechnic University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.